Drugmaker Shionogi & Co Ltd has applied for approval to make and sell its oral COVID-19
PHOTO
Drugmaker Shionogi & Co Ltd has applied for approval to make and sell its oral COVID-19 treatment in Japan, the firm said on Friday.
Known as S-217622, the drug would become the country's third antiviral pill approved for coronavirus patients, following those developed by Pfizer Inc and Merck & Co .
(Reporting by Rocky Swift; Editing by Clarence Fernandez)
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
© ZAWYA 2024
